These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11411478)

  • 41. Retrospective study of 116 patients with non-organic voice disorders: efficacy of mental imagery and laryngeal shaking.
    Voerman MS; Langeveld AP; van Rossum MA
    J Laryngol Otol; 2009 May; 123(5):528-34. PubMed ID: 18761769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spectral moments of the long-term average spectrum: sensitive indices of voice change after therapy?
    Tanner K; Roy N; Ash A; Buder EH
    J Voice; 2005 Jun; 19(2):211-22. PubMed ID: 15907436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toward improved differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia.
    Roy N; Mauszycki SC; Merrill RM; Gouse M; Smith ME
    Folia Phoniatr Logop; 2007; 59(2):83-90. PubMed ID: 17337898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales.
    Kazi R; De Cordova J; Singh A; Venkitaraman R; Nutting CM; Clarke P; Rhys-Evans P; Harrington KJ
    J Voice; 2007 Nov; 21(6):728-34. PubMed ID: 16815670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventricular dysphonia: clinical aspects and therapeutic options.
    Maryn Y; De Bodt MS; Van Cauwenberge P
    Laryngoscope; 2003 May; 113(5):859-66. PubMed ID: 12792323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of the Voice Handicap Index (VHI) and the Voice-Related Quality of Life Measure (V-RQOL).
    Portone CR; Hapner ER; McGregor L; Otto K; Johns MM
    J Voice; 2007 Nov; 21(6):723-7. PubMed ID: 16887328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The reliability and validity of patient self-rating of their own voice quality.
    Lee M; Drinnan M; Carding P
    Clin Otolaryngol; 2005 Aug; 30(4):357-61. PubMed ID: 16209679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of voice therapy in the management of vocal fold polyps and cysts.
    Cohen SM; Garrett CG
    Otolaryngol Head Neck Surg; 2007 May; 136(5):742-6. PubMed ID: 17478208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel treatment for hypophonic voice: Twang therapy.
    Lombard LE; Steinhauer KM
    J Voice; 2007 May; 21(3):294-9. PubMed ID: 16527452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The patient, his guides, his therapists. Role of the orthophonist].
    Gardeux-Zanotti V
    Rev Laryngol Otol Rhinol (Bord); 2002; 123(5):334-6. PubMed ID: 12741298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of benign laryngeal disorders with traditional methods and techniques of voice therapy.
    McFarlane SC
    Ear Nose Throat J; 1988 Jun; 67(6):425-8, 430-2, 434-5. PubMed ID: 3168852
    [No Abstract]   [Full Text] [Related]  

  • 54. Voice therapy for vocal fold paralysis.
    Miller S
    Otolaryngol Clin North Am; 2004 Feb; 37(1):105-19. PubMed ID: 15062689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Documentation of progress in voice therapy: perceptual, acoustic, and laryngostroboscopic findings pretherapy and posttherapy.
    Speyer R; Wieneke GH; Dejonckere PH
    J Voice; 2004 Sep; 18(3):325-40. PubMed ID: 15331105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of voice emission training on the improvement in voice organ function among students attending the college of teachers].
    Sliwińska-Kowalska M; Fiszer M; Kotyło P; Ziatkowska E; Stepowska M; Niebudek-Bogusz E
    Med Pr; 2002; 53(3):229-32. PubMed ID: 12369505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
    Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence-based treatment of paralytic dysphonia: making sense of outcomes and efficacy data.
    Behrman A
    Otolaryngol Clin North Am; 2004 Feb; 37(1):75-104, vi. PubMed ID: 15062688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perceived vocal morbidity in a problem asthma clinic.
    Stanton AE; Sellars C; Mackenzie K; McConnachie A; Bucknall CE
    J Laryngol Otol; 2009 Jan; 123(1):96-102. PubMed ID: 18644167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions.
    Behrman A; Sulica L; He T
    Laryngoscope; 2004 Oct; 114(10):1693-700. PubMed ID: 15454756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.